Intelligence · Clinical Development
Pipeline search results
Programs matching “eli lilly” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 169 pipeline programs matching "eli lilly" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
LOXO-LNC-24001
Eli Lilly Co.
Advanced or Metastatic Urothelial Carcinoma or Other Solid Tumors
1 trial -
LOXO-PIK-21001
Eli Lilly Co.
Advanced Breast Cancer and Other Solid Tumors
1 trial -
LY3039478
Eli Lilly and Company
Advanced Solid Tumor
1 trial -
LY3053102
Eli Lilly and Company
Healthy Volunteers
1 trial -
LY3209590 (SC)
Eli Lilly and Company
Healthy
1 trial -
LY3484356
Eli Lilly and Company
Breast Neoplasms
1 trial -
LY3493269
Eli Lilly and Company
Healthy
1 trial -
LY3493269 - SC
Eli Lilly and Company
Healthy
1 trial -
LY3532226
Eli Lilly and Company
Obesity
1 trial -
LY3537021
Eli Lilly and Company
Healthy
1 trial -
LY3819469
Eli Lilly and Company
Healthy
1 trial -
LY4006896
Eli Lilly and Company
Parkinson Disease
1 trial -
Olaratumab
Eli Lilly and Company
Malignancy
1 trial -
Olomorasib
Eli Lilly and Company
Healthy
1 trial -
Tabalumab
Eli Lilly and Company
Multiple Myeloma
1 trial -
Tirzepatide
Eli Lilly and Company
Healthy
1 trial -
Abemaciclib
Eli Lilly and Company
Breast Neoplasms
1 trial -
Abemaciclib
Eli Lilly and Company
Metastatic Breast Cancer
1 trial -
I4V-MC-JAJA
Eli Lilly Co.
Rheumatoid Arthritis
1 trial -
I6T-MC-AMCA
Eli Lilly Co.
severely active ulcerative colitis (US) and CD (Crohn’s disease)
1 trial -
Insulin Glargine
Eli Lilly and Company
Diabetes Mellitus, Type 2
1 trial -
Insulin lispro low mixture
Eli Lilly and Company
Type 2 Diabetes Mellitus
1 trial -
SELPERCATINIB, SELPERCATINIB
Eli Lilly Co.
Non Small Cell Lung Cancer; Medullary Thyroid Cancer; Colon Cancer; Breast Cancer; Pancreatic Cancer; Papillary Thyroid Cancer; Other Solid Tumors With Evidence of Activating RET Alteration;
1 trial -
premeal insulin lispro mixtures
Eli Lilly and Company
Diabetes Mellitus, Type 2
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.